-+ 0.00%
-+ 0.00%
-+ 0.00%

TENNOR THERAPEUTICS REPORTS POSITIVE PHASE IIA POC DATA FOR RIFAQUIZINONE (TNP-2092), THE FIRST NON-SURGICAL THERAPY CANDIDATE FOR PERIPROSTHETIC JOINT INFECTION

Reuters·09/10/2026 11:30:01

Please log in to view news